PLK1 and its role in the evolving landscape of KRAS-mutated colorectal cancer

被引：1
作者：
Harvey, Harry [1 ]
Chen, Eric Xueyu [1 ]
机构：
[1] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, 7-824,700 Univ Ave, Toronto, ON M5G 1Z5, Canada
来源：
JOURNAL OF GASTROINTESTINAL ONCOLOGY | 2024年 / 15卷 / 04期
关键词：
Kirsten rat sarcoma virus (KRAS); colorectal cancer (CRC); targeted therapy; RAS; INHIBITOR; FOLFIRI; BEVACIZUMAB; GEMCITABINE; COMBINATION; ISIS-2503;
D O I：
10.21037/jgo-24-323
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1987 / 1992
页数：6
相关论文
共 50 条
[31]   Reverse Engineering of DNA and RNA Hybrid Origami Structures as Targeted Nanomedicine for KRAS-Mutated Lung Cancer Therapy [J].
Ding, Xiaotong ;
Chen, Chunfa ;
Liu, Qian ;
Yang, Yao ;
Wang, Guansong ;
Qian, Hang .
ACS APPLIED POLYMER MATERIALS, 2023, 5 (08) :5880-5887
[32]   Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer [J].
Solanes-Casado, Sonia ;
Cebrian, Arancha ;
Rodriguez-Remirez, Maria ;
Mahillo, Ignacio ;
Garcia-Garcia, Laura ;
Rio-Vilarino, Anxo ;
Banos, Natalia ;
de Carcer, Guillermo ;
Monfort-Vengut, Ana ;
Castellano, Victor ;
Jesus Fernandez-Acenero, Maria ;
Garcia-Foncillas, Jesus ;
del Puerto-Nevado, Laura .
BIOMEDICINE & PHARMACOTHERAPY, 2021, 144
[33]   An Evolving Landscape: New Therapies for Metastatic Colorectal Cancer [J].
Mo, Christiana ;
Chadha, Bhawneet ;
Kuang, Chaoyuan .
CLINICAL COLORECTAL CANCER, 2024, 23 (04) :337-345
[34]   Durable responses to TAS-102 plus bevacizumab and TACE in salvage-line treatment of KRAS-mutated and MSS metastatic colorectal cancer: a case report [J].
Zhao, Wensi ;
Song, Jian .
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (07) :4805-4812
[35]   Lung Metastasis Predicts Better Prognosis in Metastatic Colorectal Cancer With Mutated KRAS [J].
Margalit, Ofer ;
Shacham-Shmueli, Einat ;
Lawrence, Yaacov R. ;
Yang, Yu-Xiao ;
Reiss, Kim A. ;
Golan, Talia ;
Mamtani, Raashi ;
Halpern, Naama ;
Aderka, Dan ;
Giantonio, Bruce ;
Boursi, Ben .
CLINICAL COLORECTAL CANCER, 2019, 18 (03) :E300-E307
[36]   An Unusual Combination: KRAS and BRAF Co-mutated Metastatic Colorectal Cancer [J].
Epperla N. ;
George B. .
Journal of Gastrointestinal Cancer, 2016, 47 (2) :206-209
[37]   Therapeutic potential of PLK1 inhibition in triple-negative breast cancer [J].
Ueda, Ai ;
Oikawa, Keiki ;
Fujita, Koji ;
Ishikawa, Akio ;
Sato, Eiichi ;
Ishikawa, Takashi ;
Kuroda, Masahiko ;
Kanekura, Kohsuke .
LABORATORY INVESTIGATION, 2019, 99 (09) :1275-1286
[38]   PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer [J].
Reda, Moataz ;
Ngamcherdtrakul, Worapol ;
Gu, Shenda ;
Bejan, Daniel S. ;
Siriwon, Natnaree ;
Gray, Joe W. ;
Yantasee, Wassana .
CANCER LETTERS, 2019, 467 :9-18
[39]   Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial [J].
Samalin, E. ;
Bouche, O. ;
Thezenas, S. ;
Francois, E. ;
Adenis, A. ;
Bennouna, J. ;
Taieb, J. ;
Desseigne, F. ;
Seitz, J. F. ;
Conroy, T. ;
Galais, M. P. ;
Assenat, E. ;
Crapez, E. ;
Poujol, S. ;
Bibeau, F. ;
Boissiere, F. ;
Laurent-Puig, P. ;
Ychou, M. ;
Mazard, T. .
BRITISH JOURNAL OF CANCER, 2014, 110 (05) :1148-1154
[40]   Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines [J].
Vitiello, Pietro Paolo ;
Cardone, Claudia ;
Martini, Giulia ;
Ciardiello, Davide ;
Belli, Valentina ;
Matrone, Nunzia ;
Barra, Giusi ;
Napolitano, Stefania ;
Della Corte, Carmina ;
Turano, Mimmo ;
Furia, Maria ;
Troiani, Teresa ;
Morgillo, Floriana ;
De Vita, Ferdinando ;
Ciardiello, Fortunato ;
Martinelli, Erika .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
12345